Log in to save to my catalogue

How many patients are eligible for disease-modifying treatment in Alzheimer’s disease? A French nati...

How many patients are eligible for disease-modifying treatment in Alzheimer’s disease? A French nati...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_56ea6c9e15a3480ab28e25a9c18588ae

How many patients are eligible for disease-modifying treatment in Alzheimer’s disease? A French national observational study over 5 years

About this item

Full title

How many patients are eligible for disease-modifying treatment in Alzheimer’s disease? A French national observational study over 5 years

Publisher

England: BMJ Publishing Group LTD

Journal title

BMJ open, 2019-06, Vol.9 (6), p.e029663-e029663

Language

English

Formats

Publication information

Publisher

England: BMJ Publishing Group LTD

More information

Scope and Contents

Contents

ObjectiveWe aimed to study the epidemiology of the prodromal and mild stages of Alzheimer’s disease (AD) patients who are eligible for clinical trials with disease-modifying therapies.SettingsWe analysed two large complementary databases to study the incidence and characteristics of this population on a nationwide scope in France from 2014 to 2018....

Alternative Titles

Full title

How many patients are eligible for disease-modifying treatment in Alzheimer’s disease? A French national observational study over 5 years

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_56ea6c9e15a3480ab28e25a9c18588ae

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_56ea6c9e15a3480ab28e25a9c18588ae

Other Identifiers

ISSN

2044-6055

E-ISSN

2044-6055

DOI

10.1136/bmjopen-2019-029663

How to access this item